Are natural killer cells the key to treating Epstein-Barr virus–associated lymphoproliferative disorders?
Robertson, Michael J.
American Society for Clinical Investigation
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=200940
- Epstein-Barr virus-associated thymidine kinase.
- Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.
- Immune regulation in Epstein-Barr virus-associated diseases.
- Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia.
- Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.